Search Results 1741-1750 of 16155 for Epilepsy (Partial Onset)

  1. Neurology - Clinical trials

    Rochester, Minn. The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia ...

  2. Neurology - Clinical trials

    Rochester, Minn. The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia ...

  3. Neurology - Clinical trials

    ... epilepsy. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS). Rochester, Minn., Jacksonville, Fla ...

  4. Publications - Jithma P. Abeykoon, M.D. - Mayo Clinic

    Assessment of fixed-duration therapies for treatment-naive Waldenstrom macroglobulinemia. ... Partial response or better at six months is prognostic of superior ...

  5. A Study to Evaluate a Standard-dose and High- dose Regimen of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

    ​​​​​​​Patients with symptomatic brain metastasis (e.g., have neurologic symptoms related to brain metastases). · Prophylactic or preventive anti-epileptic ...

  6. Primary progressive aphasia - Diagnosis and treatment - Mayo Clinic

    Find out more about this type of dementia that affects the speech and language areas of the brain.

  7. Stem Cell Transplant Strategies in Multiple Sclerosis - Translational Neuroimmunology Laboratory - Mayo Clinic Research

    Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., at Mayo Clinic: Studies how stem cells prevent neurological injury in multiple ...

  8. Tetralogy of Fallot - Diagnosis and treatment - Mayo Clinic

    These four heart problems present at birth change how blood flows through the body. Know the symptoms and treatment.

  9. New myelography protocol helps localize cerebrospinal fluid leaks - Mayo Clinic

    Image illustrates the diagnosis of a 61-year-old woman presenting with abrupt onset of Valsalva-related headache. The patient subsequently experienced ...

  10. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    ... duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator. * Is pregnant or ...